Related references
Note: Only part of the references are listed.Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States
Geeta Karadkhele et al.
CLINICAL TRANSPLANTATION (2022)
Belatacept in Kidney Transplantation: What Are the True Benefits? A Systematic Review
Yannis Lombardi et al.
FRONTIERS IN MEDICINE (2022)
Costimulation blockade and Tregs in solid organ transplantation
Moritz Muckenhuber et al.
FRONTIERS IN IMMUNOLOGY (2022)
Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity
Christian Binder et al.
FRONTIERS IN IMMUNOLOGY (2021)
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial
Dixon B. Kaufman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro
Manuel A. Podesta et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques - an experimental study
Erik Berglund et al.
TRANSPLANT INTERNATIONAL (2020)
Pharmacokinetic and pharmacodynamic study of a clinically effective anti-CD2 monoclonal antibody
Felix Sellberg et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)
CD86 Is a Selective CD28 Ligand Supporting FoxP3+Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4
Neil Halliday et al.
FRONTIERS IN IMMUNOLOGY (2020)
Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro
Christian Binder et al.
FRONTIERS IN IMMUNOLOGY (2020)
Early expansion of donor-specific Tregs in tolerant kidney transplant recipients
Thomas M. Savage et al.
JCI INSIGHT (2018)
Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients
Evelyn Katy Alvarez Salazar et al.
FRONTIERS IN IMMUNOLOGY (2017)
Increased Pretransplant Frequency of CD28+ CD4+ TEM Predicts Belatacept-Resistant Rejection in Human Renal Transplant Recipients
M. Cortes-Cerisuelo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Belatacept-Resistant Rejection Is Associated With CD28+ Memory CD8 T Cells
D. V. Mathews et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Origin of Enriched Regulatory T Cells in Patients Receiving Combined Kidney-Bone Marrow Transplantation to Induce Transplantation Tolerance
B. Sprangers et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
CD57+ CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection
J. Espinosa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28
Nicolas Poirier et al.
JOURNAL OF IMMUNOLOGY (2016)
Belatacept and Long-Term Outcomes in Kidney Transplantation
Flavio Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Long-Term Results in Recipients of Combined HLA-Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression
T. Kawai et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Inhibitory Effects of Belatacept on Allospecific Regulatory T-Cell Generation in Humans
Josh Levitsky et al.
TRANSPLANTATION (2013)
Selective Targeting of Human Alloresponsive CD8(+) Effector Memory T Cells Based on CD2 Expression
D. J. Lo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates
Tim A. Weaver et al.
NATURE MEDICINE (2009)
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation
J. A. Bluestone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression
Tatsuo Kawai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Novel insight into the agonistic mechanism of alefacept in vivo: Differentially expressed genes may serve as biomarkers of response in psoriasis patients
Asifa S. Haider et al.
JOURNAL OF IMMUNOLOGY (2007)
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-lg with potent immunosuppressive properties
CP Larsen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Analysis of human and primate CD2 molecules by protein sequence and epitope mapping with anti-human CD2 antibodies
MM Damschroder et al.
MOLECULAR IMMUNOLOGY (2004)
Share Paper
